Masivet 30 tablets

The mast cell tumor is the most common malignant skin tumor in dogs, accounting for between 16-21% of skin tumors. Their behavior and progression is quite heterogeneous ranging from distinct slow-growing tumors with low potential for metastasis to very aggressive undifferentiated tumors with plenty of metastasis.

The Masitinib, Masivet® active principle, is an inhibitor of tyrosine kinase and potently inhibits c-kit receptor selectivael.

Presentation: 50 and 150 mg. Packs of 30 tablets